Puma Biotechnology, Inc., a biopharmaceutical company announces the release of two abstracts on its drug neratinib. It will be presented at the European Society for Medical Oncology (ESMO) 2017 Congress, which is to be held from September 8 – 12 in Madrid, Spain.
Reference Link: http://markets.businessinsider.com/news/stocks/puma-biotechnology-announces-publication-of-abstracts-for-esmo-2017-1002296389
Views : 1234